Login

Tyler A. Bahr, M.D. 00:00:00

Share On Facebook Share On Twitter

Residents describe their training experience at Mayo Clinic's Department of Ophthalmology.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Wilson Romanini Discusses Vittia’s IPO, Career Journey, and Future Prospects | Wilson Romanini, CEO, Vittia Fertilizantes e Biológicos SA.
00:00:00
Jesús Martin-Garcia, Chief Executive Officer, Geneuro
00:10:00
Co-CEO Nir Bar Dea Discusses Navigating a Critical Generational Shift at Bridgewater: Insights on Talent, Culture, and Future Business Priorities
00:10:00
Eurizon's Dedication to Sustainable Asset Management |  Saverio Perissinotto ,President, Eurizon Capital.
00:10:00
David Herro, Harris Associates portfolio manager, joins 'Squawk on the Street' to discuss the potential actions of central banks globally.
00:10:00
Jim Greig: Representative of Metals Group Inc. | Jim Greig, CEO of Metals Group Inc.
00:10:00
Artemis Resources: Advancing Copper-Gold Exploration and Production at One-to-One Conference in London
00:10:00
Agriculture Innovation Mission for Climate-Smart Agriculture (AIM for Climate) | Ole Kristian Sivertsen, CEO, Desert Control AS.
00:10:00
CyanConnode's Robust Finances, Strategic Partnerships, and Promising Pipeline Propel Growth | John Cronin, Executive Chairman of cyanconnode holdings plc
00:10:00
Insights on Tech Spending, Market Trends, and Social Impact Initiatives| Robert Smith,CEO,Vista Equity Partners
00:10:00
Kingdom Holding CEO Talal Al-Mayman Discusses Four Seasons Stake Sale and Proceeds Utilization | Eng. Talal Ibrahim Almaiman, CEO, Kingdom Holding Company.
00:10:00
Differentiated diverse capabilities Customized to your needs by specialist teams|Kathryn A. Vorisek,Senior Managing Director,Mesirow Financial Consulting

© 2026 Nehu